Aman Khant, chief business officer of Guilford-based InveniAI, left, talks with Krishnan Nandabalan, the company's president and chief executive officer, at Bio 2019, an international biotech conference being held in Philadelphia this week.Photo: Contributed photo
The setting for one of the world's largest biotech conferences this week may be Philadelphia's Center City, but the presence of several New Haven technology companies is giving the proceedings a little Connecticut flavor.
Guilford-based InveniAI is one of four New Haven-area companies exhibiting at Bio 2019, one the world's largest forums for the biotech sector. More than 16,000 attendees are taking part in the conference, which concludes Thursday at the Pennsylvania Convention Center.
The other New Haven-area companies participating in the conference are:
Woodbridge-based Vistara Biosciences, which specializes in developing bioinformatics for drug discovery. Bioinformatics is the science of collecting and analyzing complex biological data such as genetic codes.
Thetis Pharamaceuticals of Branford, which is developing therapy for treating gastrointestinal disorders such as Crohn's disease and ulcerative colitis.
AlloMek Therapeutics of Woodbridge, which is developing low-toxicity treatments for cancers.